Beta-L-(-)-dioxolane cytidine (β-L-(-)-OddC) as a potent compound for the treatment of cancer

Nucleosides and Nucleotides

Volumn 16, Issue 7-9, 1997, Pages 1229-1233

  Grove, K L ^a   Quo, X ^a   Liu, S H ^a   Kukhanova, M ^a   Chu, C K ^b   Cheng, Y C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DIOXOLANE CYTIDINE; NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CONFERENCE PAPER; CYTOTOXICITY; DOSE RESPONSE; DRUG CONFORMATION; DRUG MECHANISM; HUMAN; HUMAN TISSUE; PROSTATE CARCINOMA; SOLID TUMOR;

EID: 9844262797     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319708006164     Document Type: Conference Paper

References (11)

1. Bridges, E.G. and Cheng, Y-C. Use of novel beta-L-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma. Advances in Liver Disease. 13: 231-245, 1995.
2. Chu, C.K., Ma, T., Shanmuganathan, K., Wang, C., Xiang, Y., Pai, S.B., Yao, G.Q., Sommadossi, J-P., and Cheng, Y-C. 2′-Fluoro-5-methyl-B-L-arabinofuranosyluridine (L-FMAU) as a novel antiviral agent for hepatitis B and Epstein-Barr virus. Antimicrob Agents Chemother. 39: 979-981, 1995.
3. Lin, T-S., Luo, M.Z., Liu, M.C., Pai, S.B., Dutschman, G.E. and Cheng, Y-C. Antiviral activity of 2′,3′-dideoxy-beta-L-5-fluorocytidine and 2′,3′-dideoxy-betaL-cytidine against hepatitis B virus and human immunodeficiency virus type 1 in vitro. Biochem. Pharm, 47: 171-174, 1993.
4. Chang, C.N., Doong, S.L., Zhou, J.H., Beach, J.W., Jeong, L.S., Chu, C.K. Tsai, C.H. and Cheng, Y-C. Deoxycytidine deaminase resistant stereoisomer is the active form of (±)-2′,3′-dideoxy-3′-thiacytidine in the inhibition of hepatitis B virus replication. J. Biol. Chem., 267: 13939-13942, 1992.
5. Schinazi, R.F., Chu, C.K., Peck, A., McMillan, A., Mathis, R., Cannon, D., Jeong, L.S., Beach, J.W., Choi, W.B., Yeola, S. and Liotta, D.C. Activities of the four optical isomers of 2′,3′-dideoxy-3′-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes. Antimicrob. Agents Chemother. 36: 672-676, 1992.
6. Kim, H.O., Shanmuganathan, K., Alves, A.J., Jeong, L.S., Beach, J.W., Schinazi, R.F. Chang, C.N., Cheng, Y-C., and Chu, C.K. Potent anti-HIV and anti-HBV activities of (-)-beta-L-dioxolane-C and (+)-D-beta-dioxolane T and their asymmetric syntheses. Tet. Lett., 33: 6899-6902, 1992.
7. Grove, K.L. and Cheng, Y-C. Uptake and metabolism of the new anticancer compound beta-L-(-)-dioxolane cytidine in human prostate carcinoma DU-145 cells. Cancer Res., 56: 4187-4191, 1996.
8. Grove, K.L., Quo, X., Liu, S-H., Gao, Z., Chu, C.K. and Cheng, Y-C. Anticancer activity of beta-L-(-)-dioxolane cytidine, a novel nucleoside analogue with the unnatural L configuration. Cancer Res., 55: 3008-3011, 1995.
9. Heinemann, V., Xu, Y-Z., Chubb, S., Sen, A., Hertel, L.W., Grindey, G.B. and Plunkett, W. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2′,2′-difluorodeoxycytidine. Mol. Pharmacol., 38: 567-572, 1990.
10. Kukhanova, M., Liu, S-H., Mozzherin, D., Lin, T-S., Chu, C.K. and Cheng, Y-C. L- and D-enantiomers of 2′,3′-dideoxycytidine 5′-triphosphate analogs as substrates for human DNA polymerases. J. Biol. Chem., 39: 23055-23059, 1995.
11. Gao, W.Y., Johns, D.G. and Mitsoya, H. Enzymatic assay for the quantification of deoxynucleoside triphosphates in human cells exposed to antiretroviral 2′,3′-dideoxy nucleosides. Analyt. Biochem., 222: 116, 122.